Monte Rosa Therapeutics, Inc.

{
  "main_header": {
    "sid": 1288844,
    "name": "Monte Rosa Therapeutics, Inc.",
    "stock_name": "Monte Rosa Therapeutics, Inc.",
    "full_name": "Monte Rosa Therapeutics, Inc.",
    "name_url": "stocks-analysis/monte-rosa-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "18.90",
    "chg": -2.03,
    "chgp": "-9.7%",
    "dir": -1,
    "prev_price": "20.93",
    "mcapval": "1,496.43",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US61225M1027",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "2.6 M",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/monte-rosa-therapeutics-inc-1288844-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Monte Rosa Therapeutics, Inc. Experiences Valuation Adjustment Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/monte-rosa-therapeutics-valuation-grade-changes-from-fair-to-expensive-amid-price-decline-3686371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MonteRosaTherap_valuationdot_3686371.png",
        "date": "2025-11-10 16:25:52",
        "description": "Monte Rosa Therapeutics, Inc. has recently adjusted its valuation, with its current price at $12.31. Over the past year, the company has outperformed the S&P 500, achieving a 29.17% return. Key financial metrics include a P/E ratio of 50 and a ROCE of 4.53%, indicating its unique industry position."
      }
    ],
    "total": 21,
    "sid": "1288844",
    "stock_news_url": "https://www.marketsmojo.com/news/monte-rosa-therapeutics-inc-1288844"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Monte Rosa Therapeutics, Inc. Experiences Valuation Adjustment Amid Strong Market Performance

2025-11-10 16:25:52

Monte Rosa Therapeutics, Inc. has recently adjusted its valuation, with its current price at $12.31. Over the past year, the company has outperformed the S&P 500, achieving a 29.17% return. Key financial metrics include a P/E ratio of 50 and a ROCE of 4.53%, indicating its unique industry position.

Read full news article

View All News